EW · News · 20260807N
Revenue Performance and Mix
Edwards Lifesciences Corp · 2026-08-07 · Importance 13 · Surprise 6 · In source text
Edwards Lifesciences reported $1.74 billion in revenue for the recent quarter. Quarterly EPS was $0.78, and the company exceeded earnings and revenue expectations. Edwards provided optimistic third-quarter and full-year 2026 guidance, but the digest did not provide segment revenue, geographic mix, or YoY and sequential growth rates.
Key facts
- The company reported $0.78 EPS on $1.74 billion revenue. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | unclear | realized | — | The company reported $0.78 EPS on $1.74 billion revenue. |
| net_income | unclear | realized | — | The company reported $0.78 EPS on $1.74 billion revenue. |